IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP IV, LLC

Q1 2023 Holdings

Filed 2023-05-12 | 3 holdings | $139.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tango Therapeutics, Inc.(TNGX)COM87583X109$76.5M19,363,97554.7%
Pliant Therapeutics, Inc.(PLRX)COM729139105$56.7M2,132,86740.6%
Fulcrum Therapeutics, Inc.(FULC)COM359616109$6.7M2,343,1544.8%